One Health and AMR: Why Clinicians Must Look Beyond the Ward

One Health and AMR: Why Human Health Clinicians Cannot Ignore Animal and Environmental Links

Introduction

Antimicrobial resistance is no longer a problem that clinicians can address by looking only at the prescription pad. A growing body of evidence shows that resistant bacteria move freely between hospitals, farms, rivers, and households, which means a purely clinical response to AMR will always be incomplete. For doctors, microbiologists, and hospital administrators across India, this is not an abstract academic point. It has direct bearing on which antibiotics still work, how infection control programmes are designed, and how patients are counselled.

The World Health Organization frames this interconnectedness through the One Health approach, which recognises that the health of humans, animals, and ecosystems is closely interlinked, and changes in these relationships can increase the risk of new diseases developing and spreading. AMR sits at the centre of this framework precisely because resistant organisms do not respect the boundaries between a hospital ward, a poultry farm, and a municipal drain. For Indian clinicians managing patients with recurrent urinary tract infections, hospital-acquired sepsis, or treatment failures despite seemingly appropriate antibiotic choices, understanding these non-clinical pathways is becoming part of good practice rather than an optional extra.

This article is written for doctors, hospital leaders, and healthcare associations who want a clear, clinically grounded view of why animal and environmental factors matter to AMR management, and what practical steps are already underway in India to address them.

Understanding the One Health Framework for AMR

One Health is best understood as a working principle rather than a single programme. It asks every sector that touches antibiotic use, human medicine, veterinary care, agriculture, and environmental management to coordinate rather than operate in isolation. The World Health Organization explicitly lists antimicrobial resistance as one of the priority areas where this integration is essential, alongside zoonotic diseases, vector-borne illness, and food safety.

The reasoning is straightforward once the transmission routes are laid out. A resistance gene that emerges in a bacterium on a poultry farm is not confined there. It can move into manure, then into soil and groundwater, then into crops or drinking water, and eventually into a human gut. Equally, a resistant organism amplified through inappropriate antibiotic use in a hospital can enter municipal sewage and re-enter the environment. Research synthesising human, animal, and environmental AMR data describes this as a set of interconnected loops where wastewater effluents, agricultural runoff, and foodborne transmission all facilitate the persistence and horizontal spread of resistance genes.

For practising clinicians, the operational takeaway is this: a resistant pathogen isolated from a patient may have a history that runs through a farm or a river long before it reached a ward. That history shapes how widespread the resistance already is in the local population, which has implications for empirical therapy choices.

Why This Matters More in India

India's situation adds urgency to this picture for several interlocking reasons.

• High population density combined with variable sanitation infrastructure creates ample opportunity for environmental transmission of resistant organisms.
• Antibiotics remain available without prescription in many pharmacies, a pattern documented in pharmacological research on antibiotic distribution in the country.
• A large livestock and poultry sector, much of it in the unorganised or semi-organised tier, uses antimicrobials with uneven veterinary oversight.
• Pharmaceutical manufacturing, including bulk drug production, is concentrated in specific industrial clusters, raising the stakes of effluent management.

None of these factors operates alone. They reinforce each other, which is exactly the kind of layered risk that a One Health lens is designed to capture.

Primary Pathways Linking Human, Animal, and Environmental AMR

Livestock, Poultry, and the Food Chain

Antibiotics are used in animal husbandry for treatment, disease prevention, and in some settings, growth promotion. A substantial share of what is administered does not stay in the animal. Review literature on antimicrobial resistance in livestock notes that an estimated thirty to ninety percent of administered antibiotics are excreted unchanged in urine and faeces, which means manure becomes a concentrated reservoir of antibiotic residues and resistance genes.

When that manure is applied to fields or stored in open pits, monsoon rainfall, a near-certainty across most of India for several months each year, can wash these residues into nearby water bodies and groundwater. Resistant bacteria from poultry, dairy cattle, and aquaculture can then reach humans through several routes:

• Direct contact between farm workers and animals
• Consumption of undercooked meat or unpasteurised milk
• Irrigation water carrying resistance genes into crops
• Contaminated surface water entering the drinking water supply

Clinically, this matters because the same resistance genes identified in agricultural settings, including extended-spectrum beta-lactamase markers and genes conferring resistance to tetracyclines, have also been recovered from human clinical isolates. This overlap suggests that empirical antibiotic choices in regions with intensive livestock farming may need to account for resistance patterns shaped partly outside the hospital.

Pharmaceutical Manufacturing and Industrial Effluent

India is a major global producer of bulk antibiotics, and this manufacturing base carries its own environmental footprint. Research examining discharge near pharmaceutical industrial zones has documented extremely high antibiotic concentrations in treatment plant effluent, creating what researchers describe as resistance hotspots where even native soil and water bacteria are placed under sustained selective pressure.

India has taken regulatory note of this issue. The Environment (Protection) Amendment Rules of 2019 introduced permissible antibiotic residue limits for effluents discharged by pharmaceutical manufacturing units, an early national-level effort to control antibiotic pollution from industrial sources. More recent assessments indicate that India has expanded this framework to cover discharge thresholds for a wide range of specific antibiotic compounds from manufacturing facilities, reflecting growing recognition that drug production itself can be an AMR driver, not only drug consumption.

Municipal Sewage, Hospital Effluent, and Wastewater

Hospitals, households, and municipal sewage systems all contribute antibiotic residues and resistant bacteria to wastewater. Conventional sewage treatment is not designed to fully remove these compounds. Studies of wastewater treatment plants describe them as functioning simultaneously as sources and amplification points for resistance, since dense, diverse microbial populations in treatment systems create favourable conditions for horizontal gene transfer between bacteria.

This has produced a notable silver lining for surveillance, however. Wastewater-based epidemiology, the practice of testing sewage for resistance markers, has emerged as a practical, population-level monitoring tool that does not depend on people seeking clinical care. India has already begun piloting this approach. A wastewater surveillance study from Bengaluru represents one of the first large-scale efforts in the country to use sewage testing to inform hyperlocal antibiotic prescribing, an approach with clear relevance for tier one and tier two hospitals trying to calibrate empirical therapy to local resistance realities rather than relying solely on national averages.

Aerosols, Wildlife, and Less Obvious Routes

Two pathways receive comparatively less attention but deserve mention. Bioaerosols, fine airborne particles capable of carrying viable bacteria, have been detected near poultry farms, wastewater treatment plants, and even within poorly ventilated hospital settings, raising inhalation-related exposure risks for farm workers and healthcare staff alike. Separately, wildlife such as migratory birds and urban scavenging animals have been found carrying resistant organisms picked up from contaminated environments, which they can then carry across considerable distances. Neither pathway is currently well quantified in the Indian context, but both illustrate how widely AMR has already spread beyond clinical settings.

Clinical and Diagnostic Implications for Indian Doctors

Recognising the Signature of a One Health Problem

Certain clinical patterns should prompt a clinician to consider non-clinical AMR sources rather than assuming hospital-acquired transmission alone:

• Community-acquired infections with resistance profiles typically associated with hospital-acquired organisms
• Resistance to multiple antibiotic classes in a patient with no recent hospitalisation or antibiotic use, particularly in rural or peri-urban patients with occupational exposure to livestock or untreated water
• Clusters of resistant infections in a geographic area near industrial effluent zones or large-scale poultry or dairy operations
• Recurrent infections in patients who consume raw milk or undercooked meat regularly are a relevant dietary consideration in several Indian states and tier two cities

None of these patterns confirms an environmental or zoonotic origin on its own, and clinicians should be cautious about overinterpreting any single case. They are, however, useful prompts for a broader differential when standard explanations for resistance do not fit.

What This Means for Empirical Therapy

Empirical antibiotic selection in India already varies meaningfully by region and care setting, and local antibiograms remain the most reliable guide. What a One Health perspective adds is an appreciation for why those local patterns sometimes diverge sharply from national or international guidance. A hospital located near a major poultry-producing belt or downstream from pharmaceutical manufacturing may see resistance patterns that reflect environmental antibiotic pressure as much as in-hospital prescribing history. This is one more argument, alongside the well-established case for antimicrobial stewardship, for keeping local surveillance data current rather than relying on outdated antibiograms.

Surveillance Infrastructure Clinicians Can Plug Into

India has built a meaningful surveillance infrastructure over the past decade that clinicians and hospital microbiology departments can engage with directly.

• The Indian Council of Medical Research operates the Antimicrobial Resistance Surveillance and Research Network, which tracks resistance trends across priority pathogen groups through reference laboratories at tertiary care institutions.
• The National Centre for Disease Control coordinates the National Antimicrobial Resistance Surveillance Network, which had expanded to cover medical colleges and laboratories across most states and union territories as of early 2024, using the WHONET platform for standardised data management.
• ICMR's i-AMRSS and related digital tools allow laboratories, including smaller centres, to contribute standardised AMR data to national reporting systems.

Participation in these networks, even informally through reporting unusual resistance patterns to a referral laboratory, strengthens the data that shapes national policy and helps build the kind of cross-sectoral picture that One Health containment depends on.

Policy Developments Indian Clinicians Should Know

India's policy response to AMR has matured considerably, and the most recent development is directly structured around the One Health principle. The Union Health Ministry launched the second National Action Plan on Antimicrobial Resistance, covering 2025 to 2029, during World AMR Awareness Week in November 2025. This update followed the first National Action Plan, which ran from 2017 to 2021 and laid important groundwork but faced implementation gaps, particularly around inter-sectoral coordination.

The revised plan brings a sharper structural emphasis to cross-sector accountability. It requires more than twenty key stakeholder ministries and departments, spanning human health, animal husbandry, agriculture, and environment, to develop their own action plans with defined timelines and budgets, rather than treating AMR containment as the health ministry's responsibility alone. This shift matters clinically because it signals that veterinary antibiotic regulation, effluent standards, and agricultural practice are now formally tied to the same policy framework that governs hospital antimicrobial stewardship, rather than running on separate, disconnected tracks.

For doctors and hospital administrators, awareness of this plan is useful beyond general knowledge. Many of its implementation milestones, particularly around strengthened laboratory capacity and infection control in healthcare settings, will likely translate into institutional requirements over the coming years, and early familiarity can support smoother compliance.

Practical Steps for Clinical Practice and Healthcare Institutions

Translating a One Health understanding into daily clinical and institutional practice does not require a research grant. Several actions are within reach of any hospital or clinic.

• Strengthen antimicrobial stewardship committees to include a standing review of local antibiogram trends, updated at intervals that reflect how quickly resistance patterns can shift.
• Counsel patients clearly on completing antibiotic courses, avoiding self-medication, and basic food safety practices such as thorough cooking of meat and caution with unpasteurised milk, particularly relevant given regional dietary habits.
• Engage with infection control teams to flag unusual resistance clusters that may warrant environmental or occupational history-taking, especially in patients from agricultural or industrial-adjacent communities.
• Support laboratory participation in ICMR or NCDC surveillance networks where institutional capacity allows, since broader data improves the resolution of national resistance maps.
• Stay informed on NAP-AMR 2.0 milestones relevant to healthcare facilities, since institutional readiness now often precedes formal regulatory enforcement.

These steps do not replace the foundational work of rational prescribing, but they extend a clinician's awareness beyond the four walls of the ward, which is precisely the shift that One Health asks of the medical community.

Conclusion

Antimicrobial resistance has always been a biological problem, but it has become equally a systems problem. The evidence connecting hospital resistance patterns to farms, sewage systems, and industrial effluent is now substantial enough that clinicians can no longer treat these as someone else's concern. For Indian doctors managing infections in a country with a large agricultural base, dense urban populations, and a significant pharmaceutical manufacturing sector, the One Health framework is not an abstract WHO talking point. It is a practical lens for interpreting unexplained resistance patterns, engaging with surveillance infrastructure, and contributing to a policy environment that, with NAP-AMR 2.0, has begun to formally recognise what clinicians have long observed at the bedside: resistance does not stay where it starts. A coordinated response, one that links clinical practice with veterinary regulation and environmental management, offers the only realistic path to preserving the antibiotics that remain effective.

Frequently Asked Questions

Q1: What is the One Health approach to antimicrobial resistance?

The One Health approach treats human, animal, and environmental health as one interconnected system rather than separate silos. For antimicrobial resistance, this means recognising that resistant bacteria move between hospitals, farms, water bodies, and communities, so containment efforts in clinics alone cannot succeed without parallel action in veterinary practice and environmental management.

Q2: How does antimicrobial resistance spread from animals to humans in India?

Resistant bacteria can move from livestock and poultry to humans through direct contact with animals, consumption of undercooked meat or unpasteurised milk, and contamination of water and soil with animal waste carrying resistance genes. Veterinary use of antibiotics for growth promotion and disease prevention is a recognised contributor to this chain, alongside informal farming practices common in parts of rural India.

Q3: Why is wastewater important in tracking antimicrobial resistance?

Wastewater carries antibiotic residues and resistant bacteria from hospitals, households, and pharmaceutical units, making it a useful pooled sample of resistance trends across a population. Monitoring it can reveal emerging resistance patterns earlier and more broadly than clinical testing alone, since it captures data from people who never seek formal medical care.

Q4: What is India doing to address antimicrobial resistance under One Health?

India operates AMR surveillance networks through the Indian Council of Medical Research and the National Centre for Disease Control, has set discharge limits for antibiotic residues from pharmaceutical manufacturing units, and launched the second National Action Plan on Antimicrobial Resistance for 2025 to 2029. This updated plan formally brings human health, animal husbandry, agriculture, and environment ministries into one coordinated accountability framework.

Q5: Can clinicians do anything about environmental or veterinary sources of AMR?

Yes. Clinicians can support antimicrobial stewardship in their own prescribing, report unusual resistance patterns to surveillance networks such as ICMR's AMRSN or NCDC's NARS-Net, counsel patients on appropriate antibiotic use and food safety, and engage with hospital infection control teams to investigate resistant organisms that may have non-human origins, particularly in patients with relevant occupational or dietary exposures.

#OneHealth #AntimicrobialResistance